Brian A. Niebur

Brian A. Niebur

Direttore Finanziario/CFO presso READY CREDIT CORPORATION

59 anni
Industrial Services
Communications
Finance

Provenienza dei contatti di primo grado di Brian A. Niebur

EntitàTipo di entitàSettore Industriale
Public Company Biotechnology 23
Extinct Engineering & Construction 5

Grafico delle società connesse in secondo grado

Relazione in diverse aziende

Società connesse a Brian A. Niebur tramite i suoi contatti personali

SocietàSettorePersone collegatePosizione principale
PFIZER, INC. Pharmaceuticals: Major

Robert Cohen

Corporate Officer/Principal

ST JUDE MEDICAL INC Medical Specialties

Paul Buckman

Robert Cohen

Corporate Officer/Principal

Corporate Officer/Principal

SURMODICS, INC. Medical Specialties

Jeff Ross

Lisa Heine

Corporate Officer/Principal

Director/Board Member

HYPERTENSION DIAGNOSTICS, INC. Miscellaneous Manufacturing

Kenneth Brimmer

Chief Executive Officer

UNITED THERAPEUTICS CORPORATION Pharmaceuticals: Major

Martine Rothblatt

James Edgemond

Paul Mahon

Michael Benkowitz

Chief Executive Officer

Director of Finance/CFO

General Counsel

President

Pharmaceuticals: Major

Peter Maag

Corporate Officer/Principal

CAREDX, INC Medical Specialties

Peter Maag

Director/Board Member

NUWELLIS, INC. Medical Specialties

John Erb

Paul Buckman

Chairman

Director/Board Member

HELIUS MEDICAL TECHNOLOGIES, INC. Medical Specialties

Paul Buckman

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Peter Maag

Corporate Officer/Principal

Medical Distributors

Peter Maag

Director/Board Member

College/University

Mark T. Wagner

Undergraduate Degree

Electronic Equipment/Instruments

Mark T. Wagner

Chief Executive Officer

Medical Specialties

Mark T. Wagner

Corporate Officer/Principal

Bates College College/University

Robert Cohen

Undergraduate Degree

California State University-Fullerton College/University

John Erb

Christina Campbell

Undergraduate Degree

Undergraduate Degree

University of Maine College/University

Robert Cohen

Graduate Degree

College/University

Ronald E. Eibensteiner

Jeff Ross

M. Mason Macenski

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Electronic Equipment/Instruments

Mark T. Wagner

Director/Board Member

Miscellaneous Commercial Services

Paul Buckman

Director/Board Member

Medical Specialties

William Burke

Lisa Heine

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Peter Maag

President

Pharmaceuticals: Major

Martine Rothblatt

James Edgemond

Chief Executive Officer

Director of Finance/CFO

Humboldt-Universität zu Berlin College/University

Peter Maag

Doctorate Degree

Medical Specialties

Paul Buckman

Chief Executive Officer

Pharmaceuticals: Major

Peter Maag

President

Medical/Nursing Services

Peter Maag

Director/Board Member

Pharmaceuticals: Major

Peter Maag

Corporate Officer/Principal

Miscellaneous Commercial Services

Peter Maag

Director/Board Member

Drugstore Chains

Peter Maag

President

Pharmaceuticals: Major

James Edgemond

Paul Mahon

Chief Executive Officer

Chief Executive Officer

Medical Specialties

Robert Cohen

Chief Executive Officer

Medical Distributors

Martine Rothblatt

James Edgemond

Michael Benkowitz

Director/Board Member

Director/Board Member

Director/Board Member

ZOMEDICA CORP. Pharmaceuticals: Major

Robert Cohen

Director/Board Member

Medical Specialties

Mark T. Wagner

Director/Board Member

Medical Specialties

Ronald E. Eibensteiner

Jeff Ross

Director/Board Member

Director/Board Member

Packaged Software

Mark T. Wagner

Director/Board Member

GCIi Medical, Inc.

Robert Cohen

Chief Executive Officer

Miscellaneous Commercial Services

Peter Maag

Corporate Officer/Principal

Statistiche

Distribuzione geografica

Stati Uniti 36
Germania 6
Svizzera 5
Regno Unito 3
Canada 2

Settori

Health Technology 30
Consumer Services 7
Electronic Technology 4
Commercial Services 4
Distribution Services 3

Posizioni

Director/Board Member 98
Chief Executive Officer 41
Corporate Officer/Principal 38
Chairman 29
President 26
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA